This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,764.86 Firm Fixed Price Delivery Order is for the supply of 180 tablets of 800 mg Mesalamine delayed-release tablets. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award is not designated with a set-aside requirement, indicating open competition. The contract aligns with DLA's mission to provide medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and other medical supplies, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/17/25, 10:05 AM